APA

Dempsey C., Rubio Araiz A., Bryson K. J., Finucane O., Larkin C., Mills E. L., Robertson A. A. B., Cooper M. A., O'Neill L. A. J. & Lynch M. A. (20180810). Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice. : Brain, behavior, and immunity.

Chicago

Dempsey C, Rubio Araiz A, Bryson K J, Finucane O, Larkin C, Mills E L, Robertson A A B, Cooper M A, O'Neill L A J and Lynch M A. 20180810. Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice. : Brain, behavior, and immunity.

Harvard

Dempsey C., Rubio Araiz A., Bryson K. J., Finucane O., Larkin C., Mills E. L., Robertson A. A. B., Cooper M. A., O'Neill L. A. J. and Lynch M. A. (20180810). Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice. : Brain, behavior, and immunity.

MLA

Dempsey C, Rubio Araiz A, Bryson K J, Finucane O, Larkin C, Mills E L, Robertson A A B, Cooper M A, O'Neill L A J and Lynch M A. Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice. : Brain, behavior, and immunity. 20180810.